Sign In

Kim Michelet

Director of Market Access, Team - Seagen

Kim Michelet is the Director of US Market Access Portfolio Strategy at Seagen, a biotechnology company focused on developing innovative therapies for cancer. Based in Scottsdale, Arizona, Michelet has over 16 years of experience in market access roles within the oncology sector, showcasing a strong background in navigating complex healthcare environments to improve patient access to critical therapies.13

In her current role at Seagen, Michelet is responsible for strategic initiatives that enhance market access for the company's products. Her expertise includes working with various stakeholders to ensure that patients can benefit from Seagen's innovative treatments. Prior to joining Seagen, she held significant positions in other biotech firms, contributing to her extensive knowledge and leadership in the field.34

Michelet is recognized for her results-oriented approach and has been involved in various industry discussions and initiatives aimed at improving healthcare equity and access.12

Related Questions

What is Kim Michelet's background before joining Seagen?
What specific strategies does Kim Michelet implement for market access at Seagen?
How has Kim Michelet's role evolved at Seagen over time?
What are some notable achievements of Kim Michelet in the pharmaceutical industry?
How does Kim Michelet collaborate with other departments at Seagen?
Kim Michelet
Add to my network

Location

Scottsdale, Arizona, United States